Page results
-
Information about staff who work in the Macmillan Support and Information Service.
-
Latest news and developments in the Macmillan Support and Information Service
-
Events, classes and workshops at the Macmillan Support and Information Service (MSIS)
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
This information explains when planned caesareans would be provided at The Whittington Hospital for women having antenatal care at UCLH.
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
This page explains what an intra-oral scanner is and what it is used for.
-
Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH.
-
Patient information on managing pain
File results
-
FOI2017107 Number of physical attacks on staff, patients and visitors
-
FOI/2023/0336 - Number of pagers currently in use at the Trust
-
FOI/2023/0449 - Endometriosis pathway
-
FOI/2023/0450 - Pain relief options (remifentanil, entonox and sterile water injections) during labour
-
FOI2017115 Publications relating to learning from complaints, claims, incidents, serious incidents, events and inquests
-
FOI/2023/0337 - Trac systems e-recruitment software used at the Trust
-
FOI/2023/0327 - NHS long-term plan/ prevention strategy
-
FOI/2023/0315 - Menopause Lead at the Trust
-
FOI2017110 DNRs placed upon patients
-
FOI/2023/0330 - Outsourced/ in-house occupational health provisions